National Hospital Organization Hokkaido Cancer Center ( Site 1700)

Sapporo, Hokkaido 003-0804

0 studies enrolling now · 1 studies all time

What they study most

Cervical Cancer

Studies at this site

• Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) — Completed